日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Wilson disease is a single gene disorder - comprehensive analysis of patients with prior negative genetic testing

威尔逊病是一种单基因疾病——对既往基因检测结果为阴性的患者进行全面分析

Lildballe, Dorte L; Grosen, Anne; Ott, Peter; Mohr, Isabelle; Mariño, Zoe; Coskun, Ayse K; To, Uyen; Hahn, Sihoun; Weiss, Karl Heinz; Schilsky, Michael L; Sandahl, Thomas D

Afatinib in patients with solid tumors with neuregulin 1 (NRG1) fusions: a case series from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

阿法替尼治疗伴有神经调节蛋白1 (NRG1) 融合的实体瘤患者:来自靶向药物和谱系分析应用注册研究 (TAPUR) 的病例系列

Rodon, J; Rothe, M; Mangat, P K; Garrett-Mayer, E; Cannon, T L; Hobbs, E; Kalemkerian, G P; Hinshaw, D C; Gregory, A; Grantham, G N; Halabi, S; Schilsky, R L

Prevalence of targetable genomic alterations among a diverse population participating in the ASCO TAPUR Study

ASCO TAPUR 研究中不同人群中可靶向基因组改变的患病率

Mangat, Pam K; Kirkwood, M Kelsey; Hinshaw, Dominique C; Garrett-Mayer, Elizabeth; Schilsky, Richard L

Diagnosing Wilson Disease in Acute Liver Failure: Comparison of Existing and Experimental Biomarkers

急性肝衰竭中威尔逊病的诊断:现有生物标志物与实验性生物标志物的比较

Sandahl, Thomas Damgaard; Harrington, Chris F; Kirk, Frederik Teicher; Carpenter, Geoffrey; Douglas, Leisa; Mills, Craig; Rule, Jody A; Lee, William M; Coskun, Ayse; Schilsky, Michael L

Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: A combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance)

FOLFIRI 联合贝伐单抗或西妥昔单抗治疗奥沙利铂辅助治疗患者的疗效:FIRE-3 和 CALGB/SWOG 80405 (Alliance) 的联合分析

Battaglin, Francesca; O'Neil, Bert H; Stintzing, Sebastian; Ou, Fang-Shu; Zemla, Tyler J; Niedzwiecki, Donna; Innocenti, Federico; Hochster, Howard S; von Weikersthal, Ludwig Fischer; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Heintges, Tobias; Lerchenmüller, Christian; Weiss, Lena; Heinrich, Kathrin; Goldberg, Richard M; Mayer, Robert J; Schilsky, Richard L; Blanke, Charles D; Venook, Alan P; Lenz, Heinz-Josef; Heinemann, Volker

Accurate non-ceruloplasmin bound copper: a new biomarker for the assessment and monitoring of Wilson disease patients using HPLC coupled to ICP-MS/MS

利用高效液相色谱-电感耦合等离子体质谱联用技术(HPLC-ICP-MS/MS)准确测定非铜蓝蛋白结合铜:一种用于评估和监测威尔逊病患者的新型生物标志物

Harrington, Chris F; Carpenter, Geoff; Coverdale, James P C; Douglas, Leisa; Mills, Craig; Willis, Karl; Schilsky, Michael L

Real-World Health Care Resource Utilization and Costs Associated With First-Line Dronedarone Versus First-Line Ablation in Adults With Atrial Fibrillation

真实世界中,一线使用决奈达隆与一线消融治疗成人房颤患者的医疗资源利用情况及相关成本

Greene, Stephen J; Schilsky, Samantha; Roberts, Andrew W; Kabadi, Shaum M; McKindley, David S; Preblick, Ron; Rashkin, Jason; Leeming, Reno C; Sajedian, Renee M; Russo, Andrea M

Incorporating data from multiple ongoing trials for Bayesian two-stage phase II single-arm studies

整合多个正在进行的试验的数据,用于贝叶斯两阶段 II 期单臂研究

Halabi, Susan; Choi, Taehwa; Garrett-Mayer, Elizabeth; Schilsky, Richard L; Trippa, Lorenzo

Adenoid basal cell carcinoma: An underrecognized cervical malignancy

腺样基底细胞癌:一种未被充分认识的宫颈恶性肿瘤

Katcher, Arielle; Schilsky, Juliana; Daroch, Alisha; Hernandez, Tahyna; Menzin, Andrew; Santos, Lisa Dos; Whyte, Jill; Frimer, Marina

Building Clinical and Research Delivery Networks: A Blue Print for Multidisciplinary Management and Consensus in Wilson Disease

构建临床和研究服务网络:威尔逊病多学科管理和共识的蓝图

Ala, Aftab; Liu Yin, James; Schilsky, Michael L